most cost effective glp 1 KFF Health Tracking Poll May 2024: The Public's Use and Views of GLP-1 Drugs Study finds 40% of GLP-1
Description
The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20
On March 20, 2026, Chinas patent on semaglutide (the active ingredient in Ozempic and Wegovy) expiresyears ahead of patent expirations in the U.
Doctors in the US are not clear on what is causing the side effect, but say that it has been linked to rapid weight loss.
Learn how to build a protein shake that supports muscle, digestion, and steady energy.
All of these unanswered questions only add to the urgency of determining who is most likely to benefit from GLP-1s. : Luliia Burmistrova / Getty
And Western companies are paying to license it back
